Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis Implantation
1 other identifier
interventional
120
1 country
1
Brief Summary
The researchers want to investigate the effects of muscle relaxation with rocuronium bromide during general anaesthesia on muscle trauma (serum CK, CRP) and postoperative analgesic consumption in patients with total hip prosthesis replacement (general vs. spinal anaesthesia).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2010
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 25, 2010
CompletedFirst Posted
Study publicly available on registry
October 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJune 25, 2013
June 1, 2013
2.8 years
October 25, 2010
June 22, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
degree of muscle trauma
serum CK and CRP levels are measured
24 hours
Secondary Outcomes (1)
consumption of analgetics
3 days
Study Arms (2)
general anaesthesia
EXPERIMENTALpatients receiving general anaesthesia and rocuronium bromide for muscle relaxation
spinal anaesthesia
ACTIVE COMPARATORpatients receiving spinal anaesthesia without muscle relaxation
Interventions
effect of muscle relaxation on muscle trauma, control group without relaxation
Eligibility Criteria
You may qualify if:
- patient agreement
- indication for total hip replacement
- age 55 - 80 years
- weight 65 - 95 kg
- first intervention
- ASA classification I - III
- general and spinal anaesthesia possible in this patient
You may not qualify if:
- a) neuromuscular diseases b) surgery with muscle trauma (within the last 3 months) c) permanent immobility d) intramuscular injections (within the last 4 weeks) e) medication with opioids f) medication with co-analgetics g) contraindications for general or spinal anaesthesia h) dementia, cognitive dysfunction or sleep apnea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Klinikum Hildesheim GmbHlead
- Hannover Medical Schoolcollaborator
Study Sites (1)
Klinikum Hildesheim GmbH
Hildesheim, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 25, 2010
First Posted
October 26, 2010
Study Start
September 1, 2010
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
June 25, 2013
Record last verified: 2013-06